Correlation Between GlaxoSmithKline PLC and Palram
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Palram at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Palram into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Palram, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Palram and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Palram. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Palram.
Diversification Opportunities for GlaxoSmithKline PLC and Palram
-0.94 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Palram is -0.94. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Palram in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palram and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Palram. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palram has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Palram go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Palram
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Palram. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.26 times less risky than Palram. The stock trades about -0.11 of its potential returns per unit of risk. The Palram is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 483,478 in Palram on August 28, 2024 and sell it today you would earn a total of 259,922 from holding Palram or generate 53.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 74.6% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Palram
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Palram |
GlaxoSmithKline PLC and Palram Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Palram
The main advantage of trading using opposite GlaxoSmithKline PLC and Palram positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Palram can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palram will offset losses from the drop in Palram's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Palram vs. Neto ME Holdings | Palram vs. Aryt Industries | Palram vs. Kerur Holdings | Palram vs. Globrands Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |